NCT06191107 Removable Partial Dentures Made of PEEK
| NCT ID | NCT06191107 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital Heidelberg |
| Condition | Tooth Loss |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2024-02-12 |
| Primary Completion | 2026-11 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2024-02-12 with a primary completion date of 2026-11.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
As part of the clinical study, 25 patients each were provided with removable partial dentures with clasps made of PEEK in two centres (University Hospital Heidelberg, Department of Prosthodontics and University Hospital for Dental Prosthetics Innsbruck). The patients were examined over a period of 3 years for the number and type of technical or biological complications and questioned about their oral health-related quality of life.
Eligibility Criteria
Inclusion Criteria: * Indication for a clasp-anchored removable partial denture Exclusion Criteria: * Minors and adults unable to give consent * Pregnancy or breastfeeding * Severe general illnesses * Allergies or other intolerances to one of the materials used (PEEK, PMMA) * Suspicion of lack of compliance
Contact & Investigator
Peter Rammelsberg, Prof. / Head
STUDY CHAIR
University Hospital Heidelberg
Frequently Asked Questions
Who can join the NCT06191107 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying Tooth Loss. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06191107 currently recruiting?
Yes, NCT06191107 is actively recruiting participants. Contact the research team at thomas.stober@med.uni-heidelberg.de for enrollment information.
Where is the NCT06191107 trial being conducted?
This trial is being conducted at Heidelberg, Germany.
Who is sponsoring the NCT06191107 clinical trial?
NCT06191107 is sponsored by University Hospital Heidelberg. The principal investigator is Peter Rammelsberg, Prof. / Head at University Hospital Heidelberg. The trial plans to enroll 50 participants.